Bristol-Myers tops Street 3Q forecasts
The New York-based company said it had profit of 72 cents per share. Earnings, adjusted for non-recurring costs, were 77 cents per share.
from Biotech News
The New York-based company said it had profit of 72 cents per share. Earnings, adjusted for non-recurring costs, were 77 cents per share.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments